Literature DB >> 2818563

Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells.

J Kuiper1, F J Zijlstra, J A Kamps, T J Van Berkel.   

Abstract

The major eicosanoid produced within the rat liver, prostaglandin (PG) D2, wa studied for its ability to interact with the various liver cell types. It appeared that PGD2 bound specifically to parenchymal liver cells, whereas the binding of PGD2 to Kupffer and endothelial liver cells was quantitatively unimportant. Maximally 700 pg of PGD2/mg of parenchymal-cell protein could be bound by a high-affinity site (1 x 10(6) PGD2-binding sites/cell). The recognition site for PGD2 is probably a protein because trypsin treatment of the cells virtually abolished the high-affinity binding. High-affinity binding of PGD2 was a prerequisite for the induction of a metabolic effect in isolated parenchymal liver cells, i.e. the induction of glycogenolysis. High-affinity binding of PGD2 by parenchymal cells was coupled to the conversion of PGD2 into three metabolites, whereas no conversion of PGD2 by Kupffer and endothelial liver cells was noticed. The temperature-sensitivity of the conversion of PGD2 was consistent with a conversion of PGD2 on or in the vicinity of the cell membrane. One of the PGD2 metabolites could be identified as 9 alpha, 11 beta-PGF2. It can be calculated that the conversion rate of PGD2 by parenchymal liver cells exceeds the production rate of PGD2 by Kupffer plus endothelial liver cells, indicating that PGD2 is meant to exert its activity within the liver. The present finding that PGD2 formed by the non-parenchymal liver cells is recognized by a specific receptor on parenchymal liver cells and that binding, conversion and metabolic effect of PGD2 are interlinked by this receptor provides further support for the specific role of PGD2 in the intercellular communication in the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818563      PMCID: PMC1133247          DOI: 10.1042/bj2620195

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture.

Authors:  T A Tran-Thi; K Gyufko; H Henninger; R Busse; K Decker
Journal:  J Hepatol       Date:  1987-12       Impact factor: 25.083

2.  Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization.

Authors:  J F Oram; C J Johnson; T A Brown
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

3.  Biochemical methods for the study of receptor-mediated endocytosis.

Authors:  J Harford; R D Klausner
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Prostaglandin E1 binding protein on the surface of primary cultured hepatocytes.

Authors:  T Okumura; T Sago; K Saito
Journal:  Biochem Int       Date:  1987-03

5.  Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester.

Authors:  E Casteleijn; J Kuiper; H C Van Rooij; J A Kamps; J F Koster; T J Van Berkel
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

6.  Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells.

Authors:  E Casteleijn; J Kuiper; H C van Rooij; J A Kamps; J F Koster; T J van Berkel
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

7.  Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans.

Authors:  D F Wendelborn; K Seibert; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

8.  Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes.

Authors:  D O Stene; R C Murphy
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

9.  Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats.

Authors:  M Ujihara; Y Urade; N Eguchi; H Hayashi; K Ikai; O Hayaishi
Journal:  Arch Biochem Biophys       Date:  1988-02-01       Impact factor: 4.013

10.  Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cells.

Authors:  J Kuiper; F J Zijlstra; J A Kamps; T J van Berkel
Journal:  Biochim Biophys Acta       Date:  1988-03-25
View more
  11 in total

1.  Determination of prostaglandin profiles in lipopolysaccharide-challenged guinea pig spleen.

Authors:  X Yao; Y Dai; A Johnson; M A Hass; C Feleder
Journal:  Biomed Chromatogr       Date:  2012-09-12       Impact factor: 1.902

2.  Prostaglandin F2 alpha stimulates gluconeogenesis in the perfused rat liver and this effect is blunted in livers from endotoxin infused rats.

Authors:  J A Spitzer; I V Deaciuc
Journal:  Agents Actions       Date:  1990-11

3.  Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.

Authors:  R Carroll; A Juhasz; D L Severson
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

4.  Metabolic effects of platelet-activating factor in rats in vivo. Stimulation of hepatic glycogenolysis and lipogenesis.

Authors:  R D Evans; V Ilic; D H Williamson
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

5.  Modification of hepatic protein kinase C with phorbol myristate acetate and staurosporine alters hemodynamics in the perfused rat liver.

Authors:  H Inaba; M Araki; T Numai; T Mizuguchi
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

6.  Prostaglandin E1 (PGE1) attenuates vasoconstriction induced by PGE2, PGD2 and phorbol myristate acetate in the perfused rat liver.

Authors:  H Inaba; M Araki; T Numai; T Mizuguchi
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

7.  CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice.

Authors:  Fatiha Nassir; Okunade L Adewole; Elizabeth M Brunt; Nada A Abumrad
Journal:  J Lipid Res       Date:  2013-08-20       Impact factor: 5.922

8.  Melittin stimulates liver glycogenolysis and the release of prostaglandin D2 and thromboxane B2.

Authors:  J A García-Sáinz; S M Hernández-Sotomayor; M Macías-Silva
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

9.  15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.

Authors:  Preeti Vishwakarma; Naveen Parmar; Pawan Kumar Yadav; Pragya Chandrakar; Susanta Kar
Journal:  J Mol Med (Berl)       Date:  2016-02-01       Impact factor: 4.599

10.  Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice.

Authors:  Jian H Li; Dinesh Gautam; Sung-Jun Han; Jean-Marc Guettier; Yinghong Cui; Huiyan Lu; Chuxia Deng; James O'Hare; William Jou; Oksana Gavrilova; Christoph Buettner; Jürgen Wess
Journal:  Diabetes       Date:  2009-09-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.